89bio (ETNB) has issued an announcement.
89bio, Inc. has appointed Francis Sarena as its new Chief Operating Officer, effective immediately. Mr. Sarena brings a wealth of experience from his previous high-level roles in multiple biotech companies, including Apexigen and Five Prime Therapeutics. His comprehensive background in business development and operations is complemented by a solid educational foundation with a B.S. in Finance and a J.D. He will receive an annual salary of $500,000, with the potential for a 40% bonus, and has been granted stock options and restricted stock units as part of his compensation package.
For detailed information about ETNB stock, go to TipRanks’ Stock Analysis page.
